Kesang Li

发表

Knockdown of lncRNA LINC01234 Suppresses the Tumorigenesis of Liver Cancer via Sponging miR-513a-5p

Jianwen Liu, Xin Liang, Junqing Wang, 2020, Frontiers in Oncology.

Development of GPC3 and EGFR-dual-targeting chimeric antigen receptor-T cells for adoptive T cell therapy.

Mengjie Chen, Mengmeng Huang, Jianwen Liu, 2021, American journal of translational research.

An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression

Jianren Gu, B. Shi, Zonghai Li, 2014, Cancer Immunology, Immunotherapy.

Research Progress of the Treatment of PD-1 Immune CheckpointInhibitors in Oral Squamous Cell Carcinoma

Yetao Wang, Kesang Li, S. Qian, 2020 .

The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III

B. Shi, J. Gu, Zonghai Li, 2018, Cellular Physiology and Biochemistry.

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

B. Shi, J. Gu, Zonghai Li, 2014, Clinical Cancer Research.

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma

B. Shi, Zonghai Li, Kesang Li, 2017, Cancer Immunology, Immunotherapy.

Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12

B. Shi, J. Gu, Zonghai Li, 2015, Oncotarget.

Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma

B. Shi, Zonghai Li, Shengli Yang, 2015, Oncotarget.

Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy

Kesang Li, Guoxin Hou, Yiming Jiang, 2020, Journal of Cancer Research and Clinical Oncology.

Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN− glioblastoma in vivo

B. Shi, J. Gu, Zonghai Li, 2016, Oncotarget.

Knockdown of lncRNA LINC01234 Suppresses the Tumorigenesis of Liver Cancer via Sponging miR-513a-5p

Jianwen Liu, Xin Liang, Junqing Wang, 2020, Frontiers in Oncology.

Cancer Therapy : Preclinical Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Jianren Gu, B. Shi, Zonghai Li, 2014 .

A novel EGFR isoform confers increased invasiveness to cancer cells.

Jianren Gu, Hong-Yang Wang, B. Shi, 2013, Cancer research.

Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas

G. Giamas, J. Stebbing, Kesang Li, 2022, Cancer Gene Therapy.

The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma.

Kesang Li, Q. Sha, Liqin Liu, 2020, Biomaterials science.

Corrigendum: Knockdown of lncRNA LINC01234 Suppresses the Tumorigenesis of Liver Cancer via Sponging miR-513a-5p

Jianwen Liu, Xin Liang, Junqing Wang, 2021, Frontiers in Oncology.

CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models

Kesang Li, Jingwen Zhu, Fupeng Ren, 2020, Translational cancer research.

A novel EGFR isoform confers increased invasiveness to cancer cells.

Hong-Yang Wang, B. Shi, Zonghai Li, 2013, Cancer research.